Cargando…

Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal

BACKGROUND: Diagnosis and treatment for Rheumatic Heart Disease (RHD) is inaccessible for many of the 33 million people in low and middle income countries living with this disease. More knowledge about risk factors and pathophysiologic mechanisms involved is needed in order to prevent disease and op...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorup, Lene, Hamann, Sophie Amalie, Tripathee, Ashish, Koirala, Bhagawan, Gyawali, Bishal, Neupane, Dinesh, Mota, Cleonice C., Kallestrup, Per, Hjortdal, Vibeke E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444549/
https://www.ncbi.nlm.nih.gov/pubmed/32822412
http://dx.doi.org/10.1371/journal.pone.0237924
_version_ 1783573829362122752
author Thorup, Lene
Hamann, Sophie Amalie
Tripathee, Ashish
Koirala, Bhagawan
Gyawali, Bishal
Neupane, Dinesh
Mota, Cleonice C.
Kallestrup, Per
Hjortdal, Vibeke E.
author_facet Thorup, Lene
Hamann, Sophie Amalie
Tripathee, Ashish
Koirala, Bhagawan
Gyawali, Bishal
Neupane, Dinesh
Mota, Cleonice C.
Kallestrup, Per
Hjortdal, Vibeke E.
author_sort Thorup, Lene
collection PubMed
description BACKGROUND: Diagnosis and treatment for Rheumatic Heart Disease (RHD) is inaccessible for many of the 33 million people in low and middle income countries living with this disease. More knowledge about risk factors and pathophysiologic mechanisms involved is needed in order to prevent disease and optimize treatment. This study investigated risk factors in a Nepalese population, with a special focus on Vitamin D deficiency because of its immunomodulatory effects. METHODS: Ninety-nine patients with confirmed RHD diagnosis and 97 matched, cardiac-healthy controls selected by echocardiography were recruited from hospitals in the Central and Western region of Nepal. Serum 25(OH)D concentrations were assessed using dried blood spots and anthropometric values measured to evaluate nutritional status. Conditional logistic regression analysis was used to define association between vitamin D deficiency and RHD. RESULTS: The mean age of RHD patients was 31 years (range 9–70) and for healthy controls 32 years (range 9–65), with a 4:1 female to male ratio. Vitamin D levels were lower than expected in both RDH and controls. RHD patients had lower vitamin D levels than controls with a mean s-25(OH)D concentration of 39 nmol/l (range 8.7–89.4) compared with controls 45 nmol/l (range 14.5–86.7) (p-value = 0.02). People with Vitamin D insufficiency had a higher risk (OR = 2.59; 95% CI: 1.04–6.50) of also having RHD compared to people with Vitamin D concentrations >50 nmol/l. Body mass index was significantly lower in RHD patients (22.6; 95% CI, 21.5–23.2) compared to controls (24.2; 95% CI, 23.3–25.1). CONCLUSION: RHD patients in Nepal have lower Vitamin D levels and overall poor nutritional status compared to the non-RHD controls. Longitudinal studies are needed to explore the causality between RHD and vitamin D level. Future research is also recommended among Nepali general population to confirm the low level of vitamin D as reported in our control group.
format Online
Article
Text
id pubmed-7444549
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-74445492020-08-27 Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal Thorup, Lene Hamann, Sophie Amalie Tripathee, Ashish Koirala, Bhagawan Gyawali, Bishal Neupane, Dinesh Mota, Cleonice C. Kallestrup, Per Hjortdal, Vibeke E. PLoS One Research Article BACKGROUND: Diagnosis and treatment for Rheumatic Heart Disease (RHD) is inaccessible for many of the 33 million people in low and middle income countries living with this disease. More knowledge about risk factors and pathophysiologic mechanisms involved is needed in order to prevent disease and optimize treatment. This study investigated risk factors in a Nepalese population, with a special focus on Vitamin D deficiency because of its immunomodulatory effects. METHODS: Ninety-nine patients with confirmed RHD diagnosis and 97 matched, cardiac-healthy controls selected by echocardiography were recruited from hospitals in the Central and Western region of Nepal. Serum 25(OH)D concentrations were assessed using dried blood spots and anthropometric values measured to evaluate nutritional status. Conditional logistic regression analysis was used to define association between vitamin D deficiency and RHD. RESULTS: The mean age of RHD patients was 31 years (range 9–70) and for healthy controls 32 years (range 9–65), with a 4:1 female to male ratio. Vitamin D levels were lower than expected in both RDH and controls. RHD patients had lower vitamin D levels than controls with a mean s-25(OH)D concentration of 39 nmol/l (range 8.7–89.4) compared with controls 45 nmol/l (range 14.5–86.7) (p-value = 0.02). People with Vitamin D insufficiency had a higher risk (OR = 2.59; 95% CI: 1.04–6.50) of also having RHD compared to people with Vitamin D concentrations >50 nmol/l. Body mass index was significantly lower in RHD patients (22.6; 95% CI, 21.5–23.2) compared to controls (24.2; 95% CI, 23.3–25.1). CONCLUSION: RHD patients in Nepal have lower Vitamin D levels and overall poor nutritional status compared to the non-RHD controls. Longitudinal studies are needed to explore the causality between RHD and vitamin D level. Future research is also recommended among Nepali general population to confirm the low level of vitamin D as reported in our control group. Public Library of Science 2020-08-21 /pmc/articles/PMC7444549/ /pubmed/32822412 http://dx.doi.org/10.1371/journal.pone.0237924 Text en © 2020 Thorup et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Thorup, Lene
Hamann, Sophie Amalie
Tripathee, Ashish
Koirala, Bhagawan
Gyawali, Bishal
Neupane, Dinesh
Mota, Cleonice C.
Kallestrup, Per
Hjortdal, Vibeke E.
Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal
title Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal
title_full Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal
title_fullStr Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal
title_full_unstemmed Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal
title_short Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal
title_sort evaluating vitamin d levels in rheumatic heart disease patients and matched controls: a case-control study from nepal
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444549/
https://www.ncbi.nlm.nih.gov/pubmed/32822412
http://dx.doi.org/10.1371/journal.pone.0237924
work_keys_str_mv AT thoruplene evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT hamannsophieamalie evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT tripatheeashish evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT koiralabhagawan evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT gyawalibishal evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT neupanedinesh evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT motacleonicec evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT kallestrupper evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal
AT hjortdalvibekee evaluatingvitamindlevelsinrheumaticheartdiseasepatientsandmatchedcontrolsacasecontrolstudyfromnepal